News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TetraLogic Pharmaceuticals Announces Oral Presentation of Clinical Data on Birinapant at the 2013 American Society of Clinical Oncology Annual Meeting


6/3/2013 7:10:51 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced that Phase I/II clinical data for its Smac mimetic drug candidate birinapant (formerly TL32711) were presented at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES